About
Orion Oyj A (PINK:ORINY) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
Mar 10 2026
Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026
Feb 27 2026
Orion Group Financial Statement documents 2025 and Remuneration Report published
Feb 12 2026
The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company’s key persons
Feb 12 2026
Notice to the Annual General Meeting of Orion Corporation
Financials
Revenue
$1.89 B
Market Cap
$10.7 B
P/E Ratio
18.44
EPS
2.06
Dividend Yield
4.74%
Translate